ECL ECOLAB INC.
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · NYSE · SEC CIK 31462 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.3%
TTM net income YoY4.9%
TTM EPS YoY5.6%
Revenue 3-yr CAGR4.9%
Net income 3-yr CAGR19.1%
Margins
Gross margin43.9%
Operating margin16.7%
Net margin12.0%
FCF margin10.3%
EBITDA margin20.9%
Returns
ROE20.7%
ROA7.6%
ROIC (approx.)12.1%
Asset turnover0.63x
Leverage & solvency
Liabilities / assets66.4%
Debt / equity1.27x
Current ratio1.11x
Interest coverage7.42x
Cash quality & payout
Operating cash flow / net income1.45x
Accruals ratio-3.4%
Payout ratio39.3%
Capex / revenue7.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $16.08B | $15.74B |
| Cost of revenue | $8.93B | $8.90B |
| Gross profit | $7.15B | $6.84B |
| R&D expense | $202.00M | $207.00M |
| SG&A expense | $4.26B | $4.23B |
| Operating income | $2.74B | $2.80B |
| Interest expense | $306.20M | $340.30M |
| Pretax income | $2.55B | $2.57B |
| Income tax | $454.60M | $439.30M |
| Net income | $2.08B | $2.11B |
| EBITDA | $3.41B | $3.44B |
| EPS (basic) | 7.33 | 7.43 |
| EPS (diluted) | 7.28 | 7.37 |
| Dividends declared per share | 2.68 | 2.36 |
| Weighted avg. shares (diluted) | 285.20M | 286.60M |
| Balance sheet | ||
| Cash & equivalents | $646.20M | $1.26B |
| Receivables | $3.25B | $2.87B |
| Inventory | $1.49B | $1.46B |
| Current assets | $5.96B | $6.03B |
| PP&E, net | $4.28B | $3.75B |
| Goodwill | $9.23B | $7.91B |
| Intangibles | $3.69B | $3.31B |
| Total assets | $24.70B | $22.39B |
| Current liabilities | $5.53B | $4.79B |
| Short-term debt | $870.40M | $615.70M |
| Long-term debt | $7.37B | $6.95B |
| Total debt | $8.24B | $7.56B |
| Total liabilities | $14.89B | $13.60B |
| Shareholders' equity | $9.77B | $8.76B |
| Net debt | $7.59B | $6.31B |
| Shares outstanding | 282.00M | 283.40M |
| Cash flow statement | ||
| Operating cash flow | $2.95B | $2.81B |
| Capital expenditure | $1.05B | $994.50M |
| Free cash flow | $1.90B | $1.82B |
| Investing cash flow | -$2.71B | -$433.80M |
| Financing cash flow | -$853.30M | -$2.02B |
| Depreciation & amortization | $672.60M | $634.90M |
| Stock-based compensation | $136.60M | $134.80M |
| Dividends paid | $753.60M | $664.30M |
| Share buybacks | $783.80M | $986.50M |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.